Active · per the CBE, 16 September 2026

Zygote

BE0773774443

Rechtspersoon Public limited company 1 establishment

Zygote is an IT company in Kontich. Public Limited, started on 13 September 2021, 1 establishment.

Veldkant 33 A, 2550 Kontich 034508030

Active for

5 year

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Busy address KBO

    61 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

Zygote from Kontich, company number BE0773774443, closed financial year 2025 with a result of € 290,684 after tax. For that financial year Zygote recorded revenue of € 2.3 million and equity of € 294,554. Compared with financial year 2024, the result moved from € -218,995 to € 290,684. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Growing

€ 294,554

▲ € 290,684 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 290,684

▲ still € 218,995 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 8,268

▼ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 44,554.

People and assets in 2025

Full-time equivalents

15.4

▲ 6.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.2 million

▲ 87% vs 2024

€ 80,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 156,307

▲ 48% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 263,739

▲ 84% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Revenue - € 104,282 € 1,070,373 € 2,330,017 ▲ 118%
Gross margin € -6,505 € -5,549 € 472,889 € 1,623,355 ▲ 243%
Profit after taxes € -10,016 € -17,119 € -218,995 € 290,684 ▲ € 509,679
Equity € 51,984 € 222,864 € 3,870 € 294,554 ▲ € 290,684
Total debts € 2,654 € 78,247 € 363,131 € 420,046 ▲ 16%
Cash € 4,794 € 4,549 € 12,022 € 8,268 ▼ 31%
Retained profit € -10,016 € -27,136 € -246,130 € 44,554 ▲ € 290,684
Balance sheet total € 54,638 € 301,111 € 367,001 € 714,600 ▲ 95%
Employees (FTE) - 1 8.9 15.4 ▲ 6.5

Key figures of Zygote, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Zygote?

What happened at Zygote in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • De Cronos Groep stepped down as director. NBB
  • Crosspoint Solutions stepped down as director. NBB
  • Josephus de Wit stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 290,684. Source: NBB ↗
  • New establishment in Kontich. KBO
  • Start of the company according to the CBE. KBO
  • De Cronos Groep became a director. NBB
  • Crosspoint Solutions became a director. NBB

In short

From € 10,017 loss in 2022 to € 290,684 profit in 2025.

Paid € 41,223 in corporate taxes since 2022.

Best year ever: 2025, with € 290,684 profit.

On average € 105,400 of value added per employee in 2025.

Management

The stake of De Cronos Groep comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Zygote
LabLife 90%

The shares are held by Crosspoint Solutions NV (80%) and De Cronos Groep (80%). It owns 90% of LabLife itself.

See the full network in the app

Directors

According to the 2025 annual accounts

De Cronos Groep

Director · represented by Dirk Deroost

Owns 80% via Crosspoint Solutions NV

Also active at: RESIDENCE LES ONDES, FOCUS ADVERTISING, Cronos, EECKHOUT JAN, VENTIGRATE, CRONOS PUBLIC SERVICES, Customer Link, Obycron +444 more

since 2021 · until 2027

Crosspoint Solutions

Director · represented by Ans Anthonis

since 2021 · until 2027

Josephus de Wit

Director

since 2021 · until 2027

Shareholders

Crosspoint Solutions NV · holding of De Cronos Groep

80%

Participations

Establishments

Establishment units

Physical locations of this company

Registered office

Veldkant 33 A

2550 Kontich

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0773.774.443
VAT number
BE 0773.774.443
Registered office
Veldkant 33 A, 2550 Kontich
Names & denominations
Zygote
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
13 September 2021
Peppol
Active · Active since 1 Jan 2001
Contact
034508030
Activities · NACE

Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten

Computerconsultancy-activiteiten

Frequently asked questions

What does Zygote do?
Zygote is an IT company in Kontich. Public Limited, started on 13 September 2021, 1 establishment.
What is the address of Zygote?
The registered office of Zygote is located at Veldkant 33 A, 2550 Kontich.
Is Zygote still active?
Yes. According to the CBE (16 September 2026) Zygote is active, legal situation “Normale toestand”, started on 13 September 2021.
Is Zygote registered on Peppol?
Yes, Zygote is registered on the Peppol network with ID 0208:0773774443.
What is the enterprise number of Zygote?
The enterprise number of Zygote is BE0773774443.
When was Zygote founded?
Zygote was founded on 13 September 2021.